Oncology Icons will discuss a key oncology topic selected by Targeted Oncology readers.
In July, the Targeted Oncology Icons program recognized a few community-based oncologists who all have contributed to clinical oncology research. Thus, research became the unofficial theme of the quarter.
We know that even though oncologists/hematologists working in academia play an important role in the moving new therapies forward for the treatment of cancer, oncologists in community practices also have a part to play. Specifically, real-world data (RWD) have become highly sought after information for oncologists. Regulatory bodies like the FDA also look for RWD when deciding on whether to approve a novel therapy.
As the deadline for the October Oncology Icons award approaches, the oncology community is abuzz with multiple topics that have the potential to greatly impact the future of the field.
Which topic would you like to hear and Oncology Icon discuss next?
Nominations for the Oncology Icons award program are accepted on a rolling basis throughout the year. To be eligible for the Q3 award that will be annouced in October, please submit your nomination no later than September 15, 2023. To submit, please click here.
Sanjay Juneja: ‘When There Is a Need and You Can, You Should’
April 23rd 2024In the interview with Targeted Oncology, Sanjay K. Juneja, MD, 2024 Oncology Icons honoree, discusses the transformative power of collaboration, technology, and compassionate care in shaping his career, as well as the future of cancer treatment.
Read More
Maen Hussein: ‘Every Success Motivates Us to Do Even Better’
November 16th 2023In an interview with Targeted Oncology, Maen Hussein, MD, a Q3 2023 Oncology Icons honoree, discusses his path to the community oncology setting and highlights upcoming trends in oncology he feels will improve patient outcomes.
Read More